학술논문
712TiP A phase I/II multicenter, open-label, dose-escalation, safety, pharmacodynamic, and pharmacokinetic study of Q901 administered via intravenous infusion in adult patients with selected advanced solid tumors with a cohort expansion at the recommended phase II dose
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S492-S492
Subject
Language
ISSN
0923-7534